The pivotal Phase III clinical trial will commence in Q3 2023, pending the availability of clinical supply from Procaps Group and the allocation of shortfall required to conclude Avecho’s current capital raise.
The pivotal Phase III clinical trial will commence in Q3 2023,...
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.923M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 35 | 43869108 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 44263580 | 22 |
View Market Depth
| Last trade - 16.12pm 04/10/2024 (20 minute delay) ? |
| AVE (ASX) Chart |
Day chart unavailable